Barinthus Biotherapeutics Shareholders Approve Scheme of Arrangement and Implementation Proposal

On May 20, 2026, Barinthus Biotherapeutics plc held a Court Meeting and a General Meeting of shareholders to vote on matters related to a Scheme of Arrangement. At the Barinthus Court Meeting, holders of Scheme Shares overwhelmingly approved the Scheme Proposal, with 99.98% of the value of shares voted in favor (24,709,337 shares). Similarly, at the Barinthus General Meeting, shareholders approved the Scheme Implementation Proposal with 99.98% of the votes cast in favor (24,710,187 shares). These approvals are critical steps in carrying out the Scheme Transaction as detailed in the company's proxy statement filed on April 22, 2026. Both meetings established a quorum with over 24.7 million shares represented out of approximately 40.8 million entitled to vote. The voting results reported in the filing are final, marking the successful passage of all submitted matters required to proceed with the transaction.